Thomas R Cannell Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas R Cannell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas R Cannell. Thomas R Cannell is Chief Commercial Officer in Orexigen Therapeutics, Inc. ($OREX) and EVP, Chief Commercial Officer in Orexigen Therapeutics, Inc. ($OREX) and EVP, COO, Pres Global Com Prod in Orexigen Therapeutics, Inc. ($OREX) and President and CEO in Sesen Bio, Inc. ($EBIO).
Latest Insider Trading Transactions of Thomas R Cannell
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 3.17 | 2,000,000 | 6,340,000 | 2,000,000 | |
| Feb 18 2020 | SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 0.89 | 1,450,000 | 1,292,095 | 1,450,000 | |
| Feb 25 2019 | EBIO | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 0.83 | 1,000,000 | 828,500 | 1,000,000 | |
| Oct 17 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Option Exercise | A | 0.00 | 91,200 | 0 | 91,200 | |
| Jun 02 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Grant | A | 1.55 | 2,119 | 3,284 | 3,882 | 1.8 K to 3.9 K (+120.19 %) |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Option Exercise | A | 15.00 | 72,000 | 1,080,000 | 144,000 | |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Option Exercise | A | 4.10 | 144,000 | 590,400 | 144,000 | |
| Dec 02 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Grant | A | 1.67 | 291 | 486 | 1,763 | 1.5 K to 1.8 K (+19.77 %) |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 15.00 | 31,500 | 472,500 | 31,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 15.00 | 157,500 | 2,362,500 | 157,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 4.02 | 52,500 | 211,050 | 52,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 4.02 | 262,500 | 1,055,250 | 262,500 | |
| Jun 02 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Grant | A | 0.34 | 9,632 | 3,275 | 14,723 | 5.1 K to 14.7 K (+189.20 %) |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 350,000 | 0 | 350,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 1.78 | 390,000 | 694,200 | 390,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Grant | A | 2.03 | 5,091 | 10,335 | 5,091 | 0 to 5.1 K |
| Mar 31 2015 | OREX | Orexigen Therapeut ... | Cannell Thomas R | Chief Commercial Of ... | Option Exercise | A | 7.75 | 425,000 | 3,293,750 | 425,000 |
Page: 1